Vertex Pharmaceuticals (NasdaqGS:VRTX) entered an agreement with WuXi Biologics to co-develop a trispecific T-cell Engager ...

Revenue growth in 2025 was tempered by lower entitlement growth and a moderation in upsell/cross-sell activity compared to previous periods. Management attributed 2025 customer attrition primarily to ...

Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...

Vertex, Inc. (NASDAQ: VERX) ("Vertex" or the "Company"), a leading global provider of indirect tax solutions, today announced financial results ...

Jupiter Endovascular, Inc. announced completion of patient enrollment in the SPIRARE II pivotal clinical trial evaluating the c ...

SAPinsider, the leading global community of SAP professionals, today announced the finalists for the 2026 SAPinsider Awards, recognizing organizations and leaders delivering measurable impact through ...

Eli Lilly will shell out $2.4 billion to acquire genetic medicine developer Orna Therapeutics and has committed up to $8.85 billion to launch a seventh collaboration with Innovent Biologics. Both ...

AI agents help businesses stop guessing — linking predictions to actions so teams can move from “what might happen” to ...

Influencer marketing helped AI video company Higgsfield hit $300 million in annual revenue run rate in just 11 months. But misleading marketing tactics and a shock-based social media strategy has led ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...